Firstly, monomethylauristin E can diffuse from CD30-positive lymphoma cells into the extracellular matrix and kill the surrounding CD30-negative cells, although the extent of MMAE action outside the tumour environment is unknown [52]. This evidence concerns the gene TNFRSF8 and lymphoma.